nhs procurement - cips speaker... · nhs procurement mick corti commercial & business...
TRANSCRIPT
NHS Procurement Mick Corti
Commercial & Business Development Director
NHS London Procurement Partnership
CIPS London Branch Event 8th Sept 2015
The Financial Imperative
Trusts financial challenges……2014-15 FINANCIAL HEADLINES • Collective provider deficit of £822m • Monitor : FT sector recording an overall deficit of £349m with 81 out of 152FTs (51%) now in deficit • TDA: non-FT sector recording overall deficit of £473m
• 2014-15 Provider Sector forecast deficit was £398m worse than planned
Against a backdrop of rising costs…. Non-pay
2010-11 (£18.56bn) 2011-12 (£20.61bn)
TBC
(Agency
estimated to
be around
£5bn)
2012-13 (£22.1bn) 2012-13 (£22.1bn) 2012-13 (£22.1bn)
And pay……
2010-11 (£38.3bn*) 2011-12 (£42.9bn*) 2012-13 (£43.9bn*)
*note pay costs include agency staff costs which are also included in non-pay figures
2013-14 (£45.4bn*)
Are We Surprised?
The reason for increasing
pressures on trusts’ spending is
evident from trends in hospitals’
workloads.
Trends in:
• Referrals increasing at around
3.2% per year
• Outpatients 3.2%
• A&E 1.8%
• Elective 2.8%
• eEmergency admissions 1.8%
Current Procurement Landscape
Department of Health
Commercial
medicines unit
Crown
Commercial
Service
NHS Supply
Chain
Collaborative
procurement
hubs
Procurement
teams in NHS
trusts
Suppliers
Structure of clinical and non-clinical procurement for goods and services within provider side.
NHS Supply Chain
CCS
Hubs (x6)
£1.5bn (mainly Clinical Goods)
£2.2bn (Common G&S and Agency)
c£3.0bn (Clinical, Non-clinical and Agency
Total £6.7bn
NHS Providers' Spend – 2013/14 Unless pay and pharma are addressed other savings become insignificant….
5 DH – Leading the nation’s health and care
(Agency
£2.4bn)
(Bank est.
£2.5bn)
Influence of intermediaries:
*
*Note financing costs not included in
non-pay figures on previous slide
Succession of policies to improve NHS procurement aligned to health policy (devolved NHS,
local accountability)…… but local autonomy does not maximise NHS purchasing muscle
Multiple reports have been heavily critical…... issues are symptomatic of local
autonomy:
• Lack of leadership
• Poor data and systems
• Multiple orders and invoices
• Variation in prices paid and products used
• Variable capability and capacity
• Fragmented system and culture of ‘no sharing’
• Inefficient logistics in trusts
• Competing procurement landscape confusing and costly
• No mechanism for sharing information and knowledge
• No joined up category strategies or supplier management
2 DH – Leading the nation’s health and care
Background to NHS procurement
Regtster !()(dally procurement and supply chatn news tyy ematll
Lord Carter appointed NHS procurement champion " " wanr the latest procurement and supply cham news
deltvered strarght to your mt>ox' Sign up for the SUpply
Management Da ly
20 June 2014 1 Wilt Green
Lord C •n or of Col. s has been appoint10d to thl! post of NHS
proc urem•nt champion.
The Labour peer, who has conducted a number or reviews for
the govemmen Will "help hOspitals to cut waste. save money
New Parliament = Focus on Efficiency
5 DH – Leading the nation’s health and care
*
*Note financing costs not included in
non-pay figures on previous slide
Hospital Efficiency Index
• Tightening, workflow, and step-down
• Tightening:
• Workforce
• Pharmacy
• Estates
• Procurement
• Adjusted Treatment Index
• Model of Hospital Efficiency
• Informed by cohort of 22 (now 32) provider trusts
What would procurement look like in a model hospital?
• A single NHS catalogue?
• Covering all products bought by trusts
• Supported by stores and logistics systems where possible
• Backed up by compliance policies, procedures and systems
• Phased approach: basic consumables, nurse led and doctor led products
Pay
£45.3b
Non Pay
£27.2b
Non Influence
£8.2b
Pharma
£6b
Property
£3b
Goods + Services
£9b
SERVICES
CAT.
AUTO
REPLENISH
CAT.
SPOT PURCHASE
LEAKAGE
FUTURE OPERATING MODEL WILL BE KEY
NHS London Procurement Partnership is:
• A collaborative procurement organisation funded and governed by our NHS members
• Established April 2006: Permanent
organisation since 2011
• Steering Board
• Professional, operational and process efficiencies to procurement and supply chain services
Underlying Principles
• Seeking mutual advantage for members and wider NHS
• Leverage savings for the NHS via aggregation and economies of scale
• Reduce duplication
• Increase collective influence over non-pay spend
• Collective voice to influence national agenda
• More effective resource utilisation
• Fair and equitable
NHS London Procurement Partnership focus
• Agency and Temporary Staffing
• Estates, Facilities and Professional Services
• Medical, Surgical and Supply Chain
• Medicines Optimisation and Pharmacy Procurement
• Technology
We now have £7-8bn of spend data,
and influence £3bn of that
2014-15:
Total 2006-15:
£ 103m
£ 755m
Savings
The NHS Collaborative Procurement Partnership
NHS London Procurement Partnership
North of England Commercial Procurement Collaborative
East of England Commercial Procurement Hub
NHS Commercial Solutions
• Opening up frameworks
• Reducing duplication
• Creating new national opportunities:
• National Collaborative Framework for the
supply of Nursing and Nursing related staff
• Total Orthopaedic Solutions
• Total Cardiology Solutions
Major Acute – Total Orthopaedic Solutions Framework
Phase 1
• As-Is analysis completed based on Supplier RFI data received in advance of framework
• £377k (inc VAT) cash releasing savings identified across applicable lots
• Access agreement signed, suppliers notified, pricing live within 10 days
• Implemented 1st February 2015
Phase 2
• Trust led surgeon discussion to identify resistance to change and overcome opposition
• Scenario analysis requested to highlight options available for Hips and Knees
• Options submitted to Trust for consideration
Phase 3
• Dual award selected by surgeons; Hips (65:35) and Knees (50:50)
• £435k (inc VAT) additional cash releasing savings identified from revised spend
• Rationalised from 10 Hips systems to 2 and from 6 Knee systems to 5
• Implemented 1st June 2015 with enhanced growth banding applied 1st July 2015
Total Framework savings to date - £813,542 (inc VAT)
Further rationalisation underway covering Trauma, Spinal and Extremities
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Jul-
07
Sep
-07
No
v-0
7
Jan
-08
Mar
-08
May
-08
Jul-
08
Sep
-08
No
v-0
8
Jan
-09
Mar
-09
May
-09
Jul-
09
Sep
-09
No
v-0
9
Jan
-10
Mar
-10
May
-10
Jul-
10
Sep
-10
No
v-1
0
Jan
-11
Mar
-11
May
-11
Jul-
11
Sep
-11
No
v-1
1
Jan
-12
Mar
-12
May
-12
Jul-
12
Sep
-12
No
v-1
2
Jan
-13
Mar
-13
May
-13
Jul-
13
Sep
-13
No
v-1
3
Jan
-14
Mar
-14
May
-14
Jul-
14
Sep
-14
No
v-1
4
Growth Colony Stimulating Factors (GCSF) Market Share Jul 07 to Nov 14
GRANOCYTE NEUPOGEN NEULASTA RATIOGRASTIM ZARZIO
A Medium Term Game Plan
• Consistent approaches
• Shared resources - not necessarily just people
• Supporting and enabling national strategies
• Perhaps as part of a matrixed category
environment
• Future Operating Model
• Wider services for all members, across the country
• Genuine acceptance of need for change
Thank You Any questions?
Mick Corti Commercial and Business Development Director, NHS London Procurement Partnership [email protected]